Skip to content

Real-World Study on the Intervention Effect of Individualized Cognitive Digital Therapy for Cognitive Impairment in Children with Cardiovascular Diseases

Real-World Study on the Intervention Effect of Individualized Cognitive Digital Therapy for Cognitive Impairment in Children with Cardiovascular Diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126675
Enrollment
Unknown
Registered
2026-06-13
Start date
2026-06-20
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Impairment in Children with Cardiovascular Diseases

Interventions

Control Group:Routine Treatment/Nursing Care
Intervention Group:Individualized Cognitive Digital Therapy + Routine Treatment/Nursing Care

Sponsors

Beijing Childrens Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1.Aged between 4 and 18 years; 2.Confirmed diagnosis of pediatric cardiovascular diseases (including congenital heart disease, arrhythmia, heart failure, pediatric hypertension, etc.) by an attending physician, meeting the corresponding diagnostic criteria. 3.Presence of cognitive function deficits, defined as at least one score below the norm (90 points) in the cognitive function assessment; 4.Good visual acuity or corrected visual acuity, able to complete digital assessments; 5.Fluent speech and normal communication ability; 6.Dominant hand function sufficient to complete tablet computer operations; 7.Written informed consent obtained from the child and their guardian(s).

Exclusion criteria

Exclusion criteria: 1.Presence of diseases that severely affect cognitive function: intellectual disability, intracranial tumors/space-occupying lesions, congenital or post-surgical brain tissue defects, encephalitis, ADHD, dementia, etc. 2.Severe mental disorders: schizophrenia, bipolar disorder, major depressive disorder, etc. 3.Presence of other congenital diseases; 4.Impaired function of major organs such as the liver, kidneys, or lungs; 5.Currently receiving or having received similar cognitive rehabilitation/training therapy within the past 3 months; 6.Poor adherence to assessments and interventions; 7.Incomplete clinical data; 8.Subjects judged by the researcher to require withdrawal or exclusion.

Design outcomes

Primary

MeasureTime frame
Cognitive Function: Multi-dimensional Cognitive Assessment (Attention, Executive Function, Memory, Processing Speed, Perception);

Secondary

MeasureTime frame
Emotional and Behavioral Function: Scores on scales related to anxiety, depression, social anxiety, and attention;Clinical indicators of cardiovascular diseases: cardiac function classification, heart rate, blood pressure, oxygen saturation, central venous pressure, urine output, blood gas analysis, etc.;Safety and Adherence: Training completion rate and adverse events (eye fatigue, headache, irritability, etc.);Quality of Life: PedsQL 3.0 Cardiac Module (Child Self-Report + Parent Proxy Report);

Countries

China

Contacts

Public ContactYanyan Xiao

Beijing Childrens Hospital,Capital Medical University

xiaoyanyan00@sina.com+86 10 59616776

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026